Vaccines World Asia 2019
Vaccines World Asia 2019
Vaccines World Asia 2019
The global vaccine market is projected to grow with a CAGR 5.2% in terms of value during the forecast period, 2017-2023 and reach USD 41.87 billion by 2023. Increasing funding for new vaccine development coupled with new vaccines launches in North America is expected to help it maintain its dominant share of the global vaccines market. Rising initiatives by local governments for increasing vaccination coverage in countries such as India and China are likely to boost the growth of the Asia Pacific vaccines market at a CAGR of around 7.0% from 2017 to 2025.
Product approvals from regulatory authorities coupled with subsequent product launches are expected to play a major factor in driving the growth of the global vaccines market. Players such as Emergent BioSolutions Inc., Serum Institute of India, and GlaxoSmithKline plc are increasing resorting to product launches in order to maintain the competitive advantage and carve new business opportunities.
The Inaugural Vaccines World Asia 2019 aims to provide a neutral platform to navigate the challenges faced in this industry including:
- Partnership opportunities with key Asian vaccine manufacturers from China, SEA etc.
- Regulatory challenges along the vaccine development value chain
- Case studies for Dengue, Chikungunya, Malaria, Tuberculosis amongst other key disease areas
- Vaccine development programs with key stakeholders such as GAVI, PATH etc.
- Challenges in performing and designing clinical trials for novel vaccines
- Strategies for scale-up and manufacturing productivity
- Thermostable vaccine development
- Complexities faced by stakeholders in vaccine delivery and supply chain management
The conference will host key entities in the Vaccine Industry such as Serum Institute of India, Emergent BioSolutions, Bharat Biotech, Novartis, Pfizer, Sanofi Pasteur, Johnson & Johnson, Merck & Co., MedImmune, CureVac and NIH among others and will convene on 26th and 27th November 2019.
In addition, the Inaugural vaccines World Asia 2019 will host a pre-conference Masterclass on Immunotherapy on 25th November 2019.
The immunotherapy industry is expected to skyrocket in growth from USD 61.9 billion in 2016 to USD 119.39 billion by 2021. This can be attributed to growth factors such as growing incidence of cancer and large amounts of healthcare expenditure. This session will involve Asian and International Immunotherapy companies working on monoclonal antibodies and tumor-agnostic therapies, adoptive T cell therapy, oncolytic virus therapy, non-specific immunotherapy, T cell therapy and cancer vaccines. This will be a targeted show for the Asian and Global Immunotherapy experts, biopharmas, academics, research institutes, solution providers and other stakeholders.
Vaccines World Asia will be the only vaccine focused platform in Singapore for Asia that will bring together global partners and regional stakeholders to leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation. This inaugural event will play host to the BIG Pharma, International Biopharma’s, Asian Biopharma, Academic & Research Institutes, Regulatory Authorities, NGOs, Solution Providers and Technocrats. If Asia’s vaccine business matters to you, then Vaccine World Asia 2019 is the place to be!
To Become a Speaker yourself, Contact: Aarthi Asokan Conference Producer, T: +65 3109 0159 E: email@example.com
SD Ravetkar Serum Institute of India Ltd
Ivana Haluskova Balter French Society of Immunology
Tong-Young Lee Celtec
Tanarak Plipat Department of Disease Control, Ministry of Public Health
Alexei Kirkin Cytovac
Sandy Qlintang BT Kalbe Farma
Hsiu Ling Hsiao Ever Supreme Technology
Wei Wang CARS gen
Aung Myo Tessa Therapeutics
Jianqiang Li HeBei Senlang Biotechnology Inc, Shijiazhuang Science-Technology Center Ltd
Dipti Thakkar Hummingbird Bioscience
Tina Wang Ting Ting Tessa Therapeutics
Hendri Tjandra Bayer
Steven Lee Biogenexus
Sushant Sahastrabuddhe International Vaccine Institute
Nikolai Petrovsky Flinders University and Founder of Vaxine Pty Ltd
Ajay Gambir Vaccine India Trust
Dea Mersendah PT Bio Farma
Donald Gerson Pnuvax
Wu Ke Bravovax
V.K Srinivas Bharat Biotech
Amgad Gamil Pfizer
S.S Vasan CSIRO
Sittipong Liamsuwan MSD
2019 Media Partners
Vaccines World Asia 2019 will provide commercial organizations with the opportunity to:
- Educate the market about what you offer
- Position yourselves as leaders in your field alongside key industry figures.
- Host innovative round – table sessions of up to 20 industry professionals around key topics.
- Host exclusive workshops/master-class of upto 50 end- users
- Raise brand awareness
- Enjoy the option of privately arranged meetings and consultations with selected potential clients.
- Hold face to face meetings with your target profile
This is an EXCEPTIONAL opportunity to position your brand and business before the world’s top biopharmaceutical executives. Make sure you get access to the region’s hottest life science industry sector and aren’t missing out this opportunity. See the real ROI by being part of Asia’s cellular therapy industry’s most comprehensive marketing campaign.
For more sponsorship & exhibition, contact:
Business Development Manager
T: +65 3109 0130
eBook: Christoph Conrad Presentation
eBook - Directory Of Recently Approved Vaccines
eBook - Pipelines of Asia's Vaccine Manufacturers
eBook – Exclusive Insights from Industry Experts
Vaccines World Asia 2019 Survey Report
For any queries regarding venue or accommodation, please contact:
Si Hui Sim
Senior Operations Executive
T: +65 3109 0224